DK1341790T3 - Sulfonamidoethersubstituerede imidazoquinoliner - Google Patents

Sulfonamidoethersubstituerede imidazoquinoliner

Info

Publication number: DK1341790T3
Authority: DK; Denmark
Prior art keywords: sulfonamido ether; substituted imidazoquinolines; imidazoquinolines; substituted; sulfonamido
Prior art date: 2000-12-08

Application number

DK01987283T

Other languages

English (en)

Inventor

Stephen L Crooks

George W Greisgraber

Philip D Heppner

Bryon A Merrill

Ralph R Roberts

Ai-Ping Wei

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-08

Filing date

2001-12-06

Publication date

2007-06-04

2001-12-06 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2007-06-04 Application granted granted Critical

2007-06-04 Publication of DK1341790T3 publication Critical patent/DK1341790T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
AIDS & HIV (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)

DK01987283T 2000-12-08 2001-12-06 Sulfonamidoethersubstituerede imidazoquinoliner DK1341790T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25421800P	2000-12-08	2000-12-08
PCT/US2001/046582 WO2002046190A2 (en)	2000-12-08	2001-12-06	Sulfonamido ether substituted imidazoquinolines

Publications (1)

Publication Number	Publication Date
DK1341790T3 true DK1341790T3 (da)	2007-06-04

Family

ID=22963391

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK01987283T DK1341790T3 (da)	2000-12-08	2001-12-06	Sulfonamidoethersubstituerede imidazoquinoliner
DK01987297T DK1341791T3 (da)	2000-12-08	2001-12-06	Thioethersubstituerede imidazoquinoliner
DK01992018T DK1343784T3 (da)	2000-12-08	2001-12-06	Urinstofsubstituerede imidazoquinolinethere

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK01987297T DK1341791T3 (da)	2000-12-08	2001-12-06	Thioethersubstituerede imidazoquinoliner
DK01992018T DK1343784T3 (da)	2000-12-08	2001-12-06	Urinstofsubstituerede imidazoquinolinethere

Country Status (31)

Country	Link
US (8)	US6670372B2 (da)
EP (6)	EP1341790B1 (da)
JP (7)	JP2004523498A (da)
KR (6)	KR20040028690A (da)
CN (6)	CN1247575C (da)
AR (6)	AR035664A1 (da)
AT (3)	ATE296301T1 (da)
AU (12)	AU3951702A (da)
BR (6)	BR0116032A (da)
CA (6)	CA2436984A1 (da)
CY (2)	CY1105586T1 (da)
CZ (6)	CZ303462B6 (da)
DE (3)	DE60117859T2 (da)
DK (3)	DK1341790T3 (da)
EE (6)	EE200300271A (da)
ES (3)	ES2281456T3 (da)
HR (6)	HRP20030464A2 (da)
HU (6)	HUP0400710A2 (da)
IL (6)	IL155950A0 (da)
MX (6)	MXPA03005011A (da)
NO (6)	NO20032451L (da)
NZ (6)	NZ526087A (da)
PL (7)	PL365883A1 (da)
PT (2)	PT1341791E (da)
RU (6)	RU2003116123A (da)
SI (1)	SI1341790T1 (da)
SK (6)	SK287264B6 (da)
TW (3)	TWI222972B (da)
UA (2)	UA74852C2 (da)
WO (6)	WO2002046193A2 (da)
ZA (6)	ZA200305274B (da)

Families Citing this family (209)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5741908A (en)	1996-06-21	1998-04-21	Minnesota Mining And Manufacturing Company	Process for reparing imidazoquinolinamines
UA67760C2 (uk) *	1997-12-11	2004-07-15	Міннесота Майнінг Енд Мануфакчурінг Компані	Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6541485B1 (en)	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6573273B1 (en)	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6916925B1 (en)	1999-11-05	2005-07-12	3M Innovative Properties Co.	Dye labeled imidazoquinoline compounds
JP3436512B2 (ja) *	1999-12-28	2003-08-11	株式会社デンソー	アクセル装置
US6660747B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6667312B2 (en)	2000-12-08	2003-12-23	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6545016B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Amide substituted imidazopyridines
US6664265B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6664264B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
UA74852C2 (en)	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
US6525064B1 (en)	2000-12-08	2003-02-25	3M Innovative Properties Company	Sulfonamido substituted imidazopyridines
US6660735B2 (en)	2000-12-08	2003-12-09	3M Innovative Properties Company	Urea substituted imidazoquinoline ethers
US6677347B2 (en) *	2000-12-08	2004-01-13	3M Innovative Properties Company	Sulfonamido ether substituted imidazoquinolines
US6545017B1 (en)	2000-12-08	2003-04-08	3M Innovative Properties Company	Urea substituted imidazopyridines
US6677348B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Aryl ether substituted imidazoquinolines
US7226928B2 (en) *	2001-06-15	2007-06-05	3M Innovative Properties Company	Methods for the treatment of periodontal disease
CA2467828C (en)	2001-11-29	2011-10-04	3M Innovative Properties Company	Pharmaceutical formulations comprising an immune response modifier
WO2004080430A2 (en) *	2003-03-13	2004-09-23	3M Innovative Properties Company	Methods of improving skin quality
CA2365732A1 (en)	2001-12-20	2003-06-20	Ibm Canada Limited-Ibm Canada Limitee	Testing measurements
US6677349B1 (en)	2001-12-21	2004-01-13	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
IL147953A (en) *	2002-02-01	2008-04-13	Meir Bialer	Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
PT1478327E (pt)	2002-02-22	2015-08-04	Meda Ab	Método de redução e tratamento de imunossupressão induzida por uvb
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
JP2005538057A (ja)	2002-06-07	2005-12-15	スリーエムイノベイティブプロパティズカンパニー	エーテル置換イミダゾピリジン
EP1538907A4 (en)	2002-07-02	2008-12-24	Southern Res Inst	FTSZ-HEMMER AND ITS USE
US7427629B2 (en)	2002-08-15	2008-09-23	3M Innovative Properties Company	Immunostimulatory compositions and methods of stimulating an immune response
JP2006503068A (ja)	2002-09-26	2006-01-26	スリーエムイノベイティブプロパティズカンパニー	１ｈ−イミダゾダイマー
EP1590348A1 (en) *	2002-12-20	2005-11-02	3M Innovative Properties Company	Aryl / hetaryl substituted imidazoquinolines
EP2572714A1 (en)	2002-12-30	2013-03-27	3M Innovative Properties Company	Immunostimulatory Combinations
WO2004071459A2 (en) *	2003-02-13	2004-08-26	3M Innovative Properties Company	Methods and compositions related to irm compounds and toll-like receptor 8
US7485432B2 (en)	2003-02-27	2009-02-03	3M Innovative Properties Company	Selective modulation of TLR-mediated biological activity
EP1601365A4 (en) *	2003-03-04	2009-11-11	3M Innovative Properties Co	PROPHYLACTIC TREATMENT OF UV-INDUCED EPIDERMAL NEOPLASIA
US7163947B2 (en) *	2003-03-07	2007-01-16	3M Innovative Properties Company	1-Amino 1H-imidazoquinolines
WO2004080398A2 (en) *	2003-03-07	2004-09-23	3M Innovative Properties Company	1-amino 1h-imidazoquinolines
JP2006523212A (ja) *	2003-03-13	2006-10-12	スリーエムイノベイティブプロパティズカンパニー	皮膚病変の診断方法
AU2004220465A1 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Method of tattoo removal
US20040192585A1 (en) *	2003-03-25	2004-09-30	3M Innovative Properties Company	Treatment for basal cell carcinoma
US20040265351A1 (en) *	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
AU2004244962A1 (en)	2003-04-10	2004-12-16	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
WO2004096144A2 (en) *	2003-04-28	2004-11-11	3M Innovative Properties Company	Compositions and methods for induction of opioid receptors
WO2004110991A2 (en) *	2003-06-06	2004-12-23	3M Innovative Properties Company	PROCESS FOR IMIDAZO[4,5-c]PYRIDIN-4-AMINES
WO2004110992A2 (en) *	2003-06-06	2004-12-23	3M Innovative Properties Company	Process for imidazo[4,5-c] pyridin-4-amines
WO2005016273A2 (en) *	2003-08-05	2005-02-24	3M Innovative Properties Company	Infection prophylaxis using immune response modifier compounds
MXPA06001669A (es) *	2003-08-12	2006-04-28	3M Innovative Properties Co	Compuestos que contienen imidazo-oxima sustituidos.
JP4913593B2 (ja) *	2003-08-14	2012-04-11	スリーエムイノベイティブプロパティズカンパニー	脂質修飾された免疫応答調整剤
EP2939693A1 (en) *	2003-08-14	2015-11-04	3M Innovative Properties Company	Lipid-modified immune response modifiers
AU2004266162A1 (en) *	2003-08-25	2005-03-03	3M Innovative Properties Company	Immunostimulatory combinations and treatments
JP2007503268A (ja)	2003-08-25	2007-02-22	スリーエムイノベイティブプロパティズカンパニー	免疫応答修飾化合物の送達
NZ545412A (en) *	2003-08-27	2008-12-24	Coley Pharm Group Inc	Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005020995A1 (en) *	2003-09-02	2005-03-10	3M Innovative Properties Company	Methods related to the treatment of mucosal associated conditions
JP2007504269A (ja)	2003-09-05	2007-03-01	スリーエムイノベイティブプロパティズカンパニー	Ｃｄ５＋ｂ細胞リンパ腫の治療方法
WO2005029037A2 (en) *	2003-09-17	2005-03-31	3M Innovative Properties Company	Selective modulation of tlr gene expression
US20090075980A1 (en) *	2003-10-03	2009-03-19	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and Analogs Thereof
KR101494056B1 (ko)	2003-10-03	2015-02-16	쓰리엠 이노베이티브 프로퍼티즈 컴파니	피라졸로피리딘 및 그의 유사체
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
EP1673087B1 (en)	2003-10-03	2015-05-13	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
EP1680080A4 (en) *	2003-10-31	2007-10-31	3M Innovative Properties Co	NEUTROPHILIC ACTIVATION THROUGH COMPOUNDS TO MODIFY THE IMMUNE RESPONSE
CN1906192A (zh)	2003-11-14	2007-01-31	3M创新有限公司	羟胺取代的咪唑环化合物
WO2005048933A2 (en) *	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
JP2007511575A (ja) *	2003-11-21	2007-05-10	ノバルティスアクチエンゲゼルシャフト	タンパク質キナーゼ阻害剤としての１ｈ−イミダゾキノリン誘導体
AR046845A1 (es) *	2003-11-21	2005-12-28	Novartis Ag	Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
US8778963B2 (en) *	2003-11-25	2014-07-15	3M Innovative Properties Company	Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
AU2004293078B2 (en)	2003-11-25	2012-01-19	3M Innovative Properties Company	Substituted imidazo ring systems and methods
JP2007513165A (ja) *	2003-12-02	2007-05-24	スリーエムイノベイティブプロパティズカンパニー	Ｉｒｍ化合物を含む併用薬および治療方法
WO2005076783A2 (en) *	2003-12-04	2005-08-25	3M Innovative Properties Company	Sulfone substituted imidazo ring ethers
CA2552101A1 (en) *	2003-12-29	2005-07-21	3M Innovative Properties Company	Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
JP2007517035A (ja) *	2003-12-29	2007-06-28	スリーエムイノベイティブプロパティズカンパニー	アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en)	2003-12-30	2006-09-13	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
WO2005065678A1 (en) *	2003-12-30	2005-07-21	3M Innovative Properties Company	Immunomodulatory combinations
EP1699398A4 (en) *	2003-12-30	2007-10-17	3M Innovative Properties Co	IMPROVING THE IMMUNE RESPONSE
ES2665342T3 (es)	2004-03-15	2018-04-25	Meda Ab	Formulaciones y métodos para modificadores de la respuesta inmune
US8697873B2 (en)	2004-03-24	2014-04-15	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US20070166384A1 (en) *	2004-04-09	2007-07-19	Zarraga Isidro Angelo E	Methods , composition and preparations for delivery of immune response modifiers
US20050267145A1 (en) *	2004-05-28	2005-12-01	Merrill Bryon A	Treatment for lung cancer
US20080015184A1 (en) *	2004-06-14	2008-01-17	3M Innovative Properties Company	Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines
US8017779B2 (en)	2004-06-15	2011-09-13	3M Innovative Properties Company	Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en)	2004-06-18	2006-04-13	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009832A1 (en) *	2004-06-18	2006-01-26	3M Innovative Properties Company	Substituted imidazo ring systems and methods
WO2006009826A1 (en)	2004-06-18	2006-01-26	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
AU2005283085B2 (en) *	2004-06-18	2012-06-21	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
AU2005282523A1 (en)	2004-09-02	2006-03-16	3M Innovative Properties Company	2-amino 1H imidazo ring systems and methods
WO2006026760A2 (en) *	2004-09-02	2006-03-09	3M Innovative Properties Company	1-amino imidazo-containing compounds and methods
JP5209312B2 (ja) *	2004-09-02	2013-06-12	スリーエムイノベイティブプロパティズカンパニー	１−アルコキシ１ｈ−イミダゾ環系および方法
US20080193468A1 (en) *	2004-09-08	2008-08-14	Children's Medical Center Corporation	Method for Stimulating the Immune Response of Newborns
CN101056877B (zh) *	2004-09-14	2010-06-09	诺华疫苗和诊断公司	咪唑并喹啉化合物
JP2008515928A (ja) *	2004-10-08	2008-05-15	スリーエムイノベイティブプロパティズカンパニー	Ｄｎａワクチンのためのアジュバント
JP2008523076A (ja) *	2004-12-08	2008-07-03	スリーエムイノベイティブプロパティズカンパニー	免疫調節性の組成物、合剤、および方法
US8080560B2 (en) *	2004-12-17	2011-12-20	3M Innovative Properties Company	Immune response modifier formulations containing oleic acid and methods
CA2592897A1 (en) *	2004-12-30	2006-07-13	Takeda Pharmaceutical Company Limited	1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
JP5313502B2 (ja)	2004-12-30	2013-10-09	スリーエムイノベイティブプロパティズカンパニー	置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2592904C (en)	2004-12-30	2015-04-07	3M Innovative Properties Company	Chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2005321912B2 (en)	2004-12-30	2012-04-05	3M Innovative Properties Company	Treatment for cutaneous metastases
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
JP2008530022A (ja)	2005-02-04	2008-08-07	コーリーファーマシューティカルグループ，インコーポレイテッド	免疫反応調節物質を含む水性ゲル処方物
CA2602083A1 (en)	2005-02-09	2006-08-09	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
US20080318998A1 (en)	2005-02-09	2008-12-25	Coley Pharmaceutical Group, Inc.	Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
EP1846405A2 (en)	2005-02-11	2007-10-24	3M Innovative Properties Company	Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2597446A1 (en) *	2005-02-11	2006-08-31	Coley Pharmaceutical Group, Inc.	Substituted imidazoquinolines and imidazonaphthyridines
SI2351772T1 (sl)	2005-02-18	2016-11-30	Glaxosmithkline Biologicals Sa	Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
JP2008530245A (ja)	2005-02-18	2008-08-07	ノバルティスヴァクシンズアンドダイアグノスティクス，インコーポレイテッド	尿路病原性菌株由来の抗原
AU2006223634A1 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
AU2006216686A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Method of preferentially inducing the biosynthesis of interferon
EP1851218A2 (en)	2005-02-23	2007-11-07	3M Innovative Properties Company	Hydroxyalkyl substituted imidazoquinoline compounds and methods
CA2598639A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazonaphthyridines
CA2602098A1 (en)	2005-03-14	2006-09-21	Graceway Pharmaceuticals, Llc	Method of treating actinic keratosis
CA2602590A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2602683A1 (en)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	Pyrazolopyridine-1,4-diamines and analogs thereof
JP2008539252A (ja) *	2005-04-25	2008-11-13	スリーエムイノベイティブプロパティズカンパニー	免疫活性化組成物
EP1909564A4 (en)	2005-07-18	2010-06-30	Novartis Ag	SMALL ANIMAL MODEL FOR HCV REPLICATION
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
AU2006287270A1 (en) *	2005-09-09	2007-03-15	Coley Pharmaceutical Group, Inc.	Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
US8889154B2 (en)	2005-09-15	2014-11-18	Medicis Pharmaceutical Corporation	Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
PL2368572T3 (pl)	2005-11-04	2020-11-16	Seqirus UK Limited	Szczepionki z adjuwantem z niewirionowymi antygenami otrzymane z wirusów grypy hodowanych w hodowli komórkowej
NZ567979A (en)	2005-11-04	2012-02-24	Novartis Vaccines & Diagnostic	Adjuvanted influenza vaccines including a cytokine-inducing agents which is an agonist of Toll-Like Receptor 7
ES2377884T3 (es)	2005-11-04	2012-04-02	Novartis Vaccines And Diagnostics S.R.L.	Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
WO2007056112A2 (en)	2005-11-04	2007-05-18	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
WO2007052155A2 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
BR122019013216B8 (pt)	2006-01-27	2021-07-27	Seqirus Uk Ltd	ensaio imunológico para análise de uma vacina contra influenza
EP1988896A4 (en)	2006-02-22	2011-07-27	3M Innovative Properties Co	CONJUGATES TO MODIFY IMMUNE REACTIONS
WO2007106854A2 (en)	2006-03-15	2007-09-20	Coley Pharmaceutical Group, Inc.	Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
WO2007109813A1 (en)	2006-03-23	2007-09-27	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
US20100010217A1 (en) *	2006-03-23	2010-01-14	Valiante Nicholas M	Methods for the preparation of imidazole-containing compounds
EP2007765B1 (en) *	2006-03-23	2012-06-27	Novartis AG	Immunopotentiating compounds
JP2009534303A (ja)	2006-03-24	2009-09-24	ノバルティスヴァクシンズアンドダイアグノスティクスゲーエムベーハーアンドカンパニーカーゲー	冷蔵しないインフルエンザワクチンの保存
US20100285062A1 (en)	2006-03-31	2010-11-11	Novartis Ag	Combined mucosal and parenteral immunization against hiv
ATE522541T1 (de)	2006-06-09	2011-09-15	Novartis Ag	Bakterielle adhäsine konformere
WO2008008432A2 (en)	2006-07-12	2008-01-17	Coley Pharmaceutical Group, Inc.	Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
EP2586790A3 (en)	2006-08-16	2013-08-14	Novartis AG	Immunogens from uropathogenic Escherichia coli
US8178539B2 (en)	2006-09-06	2012-05-15	3M Innovative Properties Company	Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
EP3456348B1 (en)	2006-09-11	2025-03-26	Seqirus UK Limited	Making influenza virus vaccines without using eggs
PL2121011T3 (pl)	2006-12-06	2014-10-31	Novartis Ag	Szczepionki zawierające antygeny czterech szczepów wirusa grypy
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
GB0700562D0 (en)	2007-01-11	2007-02-21	Novartis Vaccines & Diagnostic	Modified Saccharides
CN101784283A (zh)	2007-06-27	2010-07-21	诺华有限公司	低添加流感疫苗
GB0714963D0 (en)	2007-08-01	2007-09-12	Novartis Ag	Compositions comprising antigens
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
MX2010007699A (es) *	2008-01-15	2010-08-04	Meda Ab	Tratamiento de enfermedades del colon o prevencion de carcinoma colorrectal con derivados de imidazoquinolina.
ES2546213T3 (es) *	2008-03-03	2015-09-21	Novartis Ag	Compuestos y composiciones como moduladores de la actividad de TLR
EP2268309B1 (en)	2008-03-18	2015-01-21	Novartis AG	Improvements in preparation of influenza virus vaccine antigens
CN102438650A (zh)	2009-03-06	2012-05-02	诺华有限公司	衣原体抗原
AU2010229835B2 (en)	2009-03-25	2015-01-15	The Board Of Regents Of The University Of Texas System	Compositions for stimulation of mammalian innate immune resistance to pathogens
NZ612315A (en)	2009-04-14	2014-10-31	Novartis Ag	Compositions for immunising against staphylococcus aureus
FR2949344A1 (fr)	2009-04-27	2011-03-04	Novartis Ag	Vaccins de protection contre la grippe
AU2013203591B2 (en) *	2009-05-01	2017-01-19	University Court Of The University Of Dundee	Treatment or prophylaxis of proliferative conditions
GB0907551D0 (en)	2009-05-01	2009-06-10	Univ Dundee	Treatment or prophylaxis of proliferative conditions
TW201116294A (en)	2009-07-15	2011-05-16	Novartis Ag	RSV F protein compositions and methods for making same
SI2464658T1 (sl)	2009-07-16	2015-02-27	Novartis Ag	Detoksificirani imunogeni escherichie coli
GB0918392D0 (en)	2009-10-20	2009-12-02	Novartis Ag	Diagnostic and therapeutic methods
GB0919690D0 (en)	2009-11-10	2009-12-23	Guy S And St Thomas S Nhs Foun	compositions for immunising against staphylococcus aureus
GB201009861D0 (en)	2010-06-11	2010-07-21	Novartis Ag	OMV vaccines
LT2606047T (lt)	2010-08-17	2017-04-10	3M Innovative Properties Company	Imuninio atsako modifikatoriaus junginio lipidizuotos kompozicijos, sudėtys ir būdai
WO2012080728A1 (en)	2010-12-16	2012-06-21	Astrazeneca Ab	Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy
EP4144368B1 (en)	2011-01-26	2025-02-26	GlaxoSmithKline Biologicals S.A.	Rsv immunization regimen
CN103842374A (zh)	2011-05-13	2014-06-04	诺华股份有限公司	融合前的rsv f抗原
US8728486B2 (en)	2011-05-18	2014-05-20	University Of Kansas	Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
EP2717919B1 (en)	2011-06-03	2016-08-03	3M Innovative Properties Company	Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
CA2838023C (en)	2011-06-03	2019-08-13	3M Innovative Properties Company	Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
US20130023736A1 (en)	2011-07-21	2013-01-24	Stanley Dale Harpstead	Systems for drug delivery and monitoring
WO2013068949A1 (en)	2011-11-07	2013-05-16	Novartis Ag	Carrier molecule comprising a spr0096 and a spr2021 antigen
WO2013108272A2 (en)	2012-01-20	2013-07-25	International Centre For Genetic Engineering And Biotechnology	Blood stage malaria vaccine
CN103566377A (zh)	2012-07-18	2014-02-12	上海博笛生物科技有限公司	癌症的靶向免疫治疗
AU2014203896B2 (en)	2013-01-07	2018-05-31	The Trustees Of The University Of Pennsylvania	Compositions and methods for treating cutaneous T cell lymphoma
US9919029B2 (en)	2013-07-26	2018-03-20	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of bacterial infections
EP3065741B1 (en)	2013-11-05	2021-09-22	3M Innovative Properties Company	Sesame oil based injection formulations
EP2870974A1 (en)	2013-11-08	2015-05-13	Novartis AG	Salmonella conjugate vaccines
EP3092255A4 (en)	2014-01-10	2017-09-20	Birdie Biopharmaceuticals Inc.	Compounds and compositions for treating egfr expressing tumors
AU2015238512B2 (en)	2014-03-26	2018-02-01	Glaxosmithkline Biologicals S.A.	Mutant staphylococcal antigens
CA2954446A1 (en)	2014-07-09	2016-01-14	Shanghai Birdie Biotech, Inc.	Anti-pd-l1 combinations for treating tumors
CN112546230A (zh) *	2014-07-09	2021-03-26	博笛生物科技有限公司	用于治疗癌症的联合治疗组合物和联合治疗方法
CN105461767B (zh) *	2014-08-07	2019-03-12	富力	一种连翘苷的化学合成方法
CN112546238A (zh)	2014-09-01	2021-03-26	博笛生物科技有限公司	用于治疗肿瘤的抗-pd-l1结合物
WO2016044839A2 (en)	2014-09-19	2016-03-24	The Board Of Regents Of The University Of Texas System	Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
CN108137586B (zh) *	2015-09-14	2021-04-13	辉瑞大药厂	作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
EP3356371A4 (en) *	2015-09-29	2020-06-24	The University of Chicago	POLYMER CONJUGATE VACCINE
WO2017059280A1 (en)	2015-10-02	2017-04-06	The University Of North Carolina At Chapel Hill	Novel pan-tam inhibitors and mer/axl dual inhibitors
CN106943598A (zh)	2016-01-07	2017-07-14	博笛生物科技（北京）有限公司	用于治疗肿瘤的抗-her2组合
CN115554406A (zh)	2016-01-07	2023-01-03	博笛生物科技有限公司	用于治疗肿瘤的抗-cd20组合
CN115252792A (zh)	2016-01-07	2022-11-01	博笛生物科技有限公司	用于治疗肿瘤的抗-egfr组合
JP7145853B2 (ja)	2016-11-09	2022-10-03	ザボードオブリージェンツオブザユニバーシティーオブテキサスシステム	適応免疫調節のための方法および組成物
CN118515666A (zh)	2017-04-27	2024-08-20	博笛生物科技有限公司	2-氨基-喹啉衍生物
KR20200019226A (ko)	2017-06-23	2020-02-21	버디 바이오파마슈티칼즈, 인크.	약학 조성물
EP3728255B1 (en)	2017-12-20	2022-01-26	3M Innovative Properties Company	Amide substituted imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier
AU2019216531A1 (en)	2018-02-02	2020-09-24	Maverix Oncology, Inc.	Small molecule drug conjugates of gemcitabine monophosphate
CN111788202B (zh) *	2018-02-28	2024-03-01	3M创新有限公司	具有N-1支链基团的经取代的咪唑并[4,5-c]喹啉化合物
WO2019166946A1 (en)	2018-02-28	2019-09-06	Pfizer Inc.	Il-15 variants and uses thereof
BR112020022595A2 (pt)	2018-05-23	2021-02-09	Pfizer Inc.	anticorpos específicos para gucy2c e usos dos mesmos
DK3797121T3 (da)	2018-05-23	2024-07-08	Pfizer	Antistoffer, der er specifikke for CD3, og anvendelser deraf
CA3101277A1 (en)	2018-05-24	2019-11-28	3M Innovative Properties Company	N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods
AU2019311102A1 (en) *	2018-07-24	2021-02-25	Torque Therapeutics, Inc	TLR7/8 agonists and liposome compositions
US12024514B2 (en)	2018-11-26	2024-07-02	Solventum Intellectual Properties Company	N-1 branched alkyl ether substituted imidazo[4,5-c]quinoline compounds, compositions, and methods
WO2020128893A1 (en)	2018-12-21	2020-06-25	Pfizer Inc.	Combination treatments of cancer comprising a tlr agonist
CN114616234B (zh) *	2019-02-07	2024-04-12	康威(广州)生物科技有限公司	磷咪唑并喹啉胺衍生物、及其药物组合物和应用
CN119455003A (zh)	2019-02-12	2025-02-18	Ambrx公司	包含抗体-tlr激动剂缀合物的组合物、方法和用途
IL325102A (en)	2019-03-27	2026-02-01	Merck Patent Gmbh	History of Imidazolonylquinilines and their medical uses
CN114599360A (zh) *	2019-10-29	2022-06-07	骏达贸易有限公司	4-氨基-咪唑并喹啉化合物及其用途
WO2021116420A1 (en)	2019-12-13	2021-06-17	INSERM (Institut National de la Santé et de la Recherche Médicale)	Use of tlr7 and/or tlr8 agonists for the treatment of leptospirosis
US11702474B2 (en)	2019-12-17	2023-07-18	Pfizer Inc.	Antibodies specific for CD47, PD-L1, and uses thereof
CA3189590A1 (en)	2020-07-17	2022-01-20	Pfizer Inc.	Therapeutic antibodies and their uses
AU2021327396A1 (en)	2020-08-20	2023-03-23	Ambrx, Inc.	Antibody-TLR agonist conjugates, methods and uses thereof
WO2022130046A1 (en) *	2020-12-16	2022-06-23	3M Innovative Properties Company	N-1 branched imidazoquinolines, conjugates thereof, and methods
WO2025104289A1 (en)	2023-11-17	2025-05-22	Medincell S.A.	Antineoplastic combinations

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2135210A (en) *	1937-03-13	1938-11-01	John R Farrar	Golf ball
US3314941A (en)	1964-06-23	1967-04-18	American Cyanamid Co	Novel substituted pyridodiazepins
US3692907A (en) *	1970-10-27	1972-09-19	Richardson Merrell Inc	Treating viral infections with bis-basic ethers and thioethers of fluorenone and fluorene and pharmaceutical compositons of the same
US3819190A (en) *	1972-10-02	1974-06-25	D Nepela	Golf ball
US4284276A (en) *	1980-02-13	1981-08-18	Worst Joseph C	Grooved golf ball
CA1271477A (en) *	1983-11-18	1990-07-10	John F. Gerster	1h-imidazo[4,5-c]quinolin-4-amines
ZA848968B (en)	1983-11-18	1986-06-25	Riker Laboratories Inc	1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en)	1983-11-18	1990-12-23	Riker Laboratories Inc	1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
JPH0327380Y2 (da)	1985-05-22	1991-06-13
US4880779A (en) *	1987-07-31	1989-11-14	Research Corporation Technologies, Inc.	Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
US5238944A (en)	1988-12-15	1993-08-24	Riker Laboratories, Inc.	Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
DK0385630T3 (da)	1989-02-27	1997-05-12	Riker Laboratories Inc	1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
US5756747A (en)	1989-02-27	1998-05-26	Riker Laboratories, Inc.	1H-imidazo 4,5-c!quinolin-4-amines
US5037986A (en)	1989-03-23	1991-08-06	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US4929624A (en)	1989-03-23	1990-05-29	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
NZ232740A (en)	1989-04-20	1992-06-25	Riker Laboratories Inc	Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
US4988815A (en) *	1989-10-26	1991-01-29	Riker Laboratories, Inc.	3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5054153A (en) *	1989-12-01	1991-10-08	Silliman Paul D	Golf club cleaner
CA2093132C (en) *	1990-10-05	2002-02-26	John F. Gerster	Process for the preparation of imidazo[4,5-c]quinolin-4-amines
EP0872478B1 (en)	1991-03-01	2002-12-18	Minnesota Mining And Manufacturing Company	Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5389640A (en)	1991-03-01	1995-02-14	Minnesota Mining And Manufacturing Company	1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5175296A (en) *	1991-03-01	1992-12-29	Minnesota Mining And Manufacturing Company	Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
US5268376A (en)	1991-09-04	1993-12-07	Minnesota Mining And Manufacturing Company	1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
PH31245A (en) *	1991-10-30	1998-06-18	Janssen Pharmaceutica Nv	1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5266575A (en)	1991-11-06	1993-11-30	Minnesota Mining And Manufacturing Company	2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en)	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
FR2692159B1 (fr) *	1992-06-10	1996-10-11	Vartan Berberian	Boule pour jeux de boules et procedes d'obtention d'une telle boule.
US5395937A (en) *	1993-01-29	1995-03-07	Minnesota Mining And Manufacturing Company	Process for preparing quinoline amines
KR100341341B1 (ko)	1993-07-15	2002-11-25	미네소타 마이닝 앤드 매뉴팩춰링 캄파니	이미다조[4,5-c]피리딘-4-아민
US5648516A (en)	1994-07-20	1997-07-15	Minnesota Mining And Manufacturing Company	Fused cycloalkylimidazopyridines
US5352784A (en) *	1993-07-15	1994-10-04	Minnesota Mining And Manufacturing Company	Fused cycloalkylimidazopyridines
US5644063A (en)	1994-09-08	1997-07-01	Minnesota Mining And Manufacturing Company	Imidazo[4,5-c]pyridin-4-amine intermediates
US5482936A (en)	1995-01-12	1996-01-09	Minnesota Mining And Manufacturing Company	Imidazo[4,5-C]quinoline amines
JPH09116911A (ja) *	1995-10-20	1997-05-02	Canon Inc	撮像システム
JPH09208584A (ja)	1996-01-29	1997-08-12	Terumo Corp	アミド誘導体、およびそれを含有する医薬製剤、および合成中間体
JPH09255926A (ja)	1996-03-26	1997-09-30	Diatex Co Ltd	粘着テープ
US5741908A (en) *	1996-06-21	1998-04-21	Minnesota Mining And Manufacturing Company	Process for reparing imidazoquinolinamines
US5693811A (en) *	1996-06-21	1997-12-02	Minnesota Mining And Manufacturing Company	Process for preparing tetrahdroimidazoquinolinamines
US5759109A (en) *	1996-09-09	1998-06-02	Martini; Byron Rocco	Simulated golf ball instructional device
HUP9904665A3 (en)	1996-10-25	2000-11-28	Minnesota Mining And Mfg Co Sa	Immune response modifier compounds for treatment of th2 mediated and related diseases
US5939090A (en)	1996-12-03	1999-08-17	3M Innovative Properties Company	Gel formulations for topical drug delivery
JP4101302B2 (ja)	1997-01-09	2008-06-18	テルモ株式会社	新規アミド誘導体および合成中間体
UA67760C2 (uk)	1997-12-11	2004-07-15	Міннесота Майнінг Енд Мануфакчурінг Компані	Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
JPH11222432A (ja)	1998-02-03	1999-08-17	Terumo Corp	インターフェロンを誘起するアミド誘導体を含有する外用剤
JPH11255926A (ja)	1998-03-13	1999-09-21	Toray Ind Inc	シリコーン成型品およびその製造方法
CN1220997C (zh) *	1998-05-22	2005-09-28	松下电器产业株式会社	电解电容器及其制造方法
US6110929A (en)	1998-07-28	2000-08-29	3M Innovative Properties Company	Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
JP2000119271A (ja)	1998-08-12	2000-04-25	Hokuriku Seiyaku Co Ltd	１ｈ―イミダゾピリジン誘導体
US20020058674A1 (en) *	1999-01-08	2002-05-16	Hedenstrom John C.	Systems and methods for treating a mucosal surface
NZ512628A (en) *	1999-01-08	2004-03-26	3M Innovative Properties Co	Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
EP1495758A3 (en)	1999-01-08	2005-04-13	3M Innovative Properties Company	Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US6558951B1 (en)	1999-02-11	2003-05-06	3M Innovative Properties Company	Maturation of dendritic cells with immune response modifying compounds
JP2000247884A (ja)	1999-03-01	2000-09-12	Sumitomo Pharmaceut Co Ltd	アラキドン酸誘発皮膚疾患治療剤
US6756382B2 (en)	1999-06-10	2004-06-29	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6541485B1 (en)	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6573273B1 (en) *	1999-06-10	2003-06-03	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6376669B1 (en)	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
US6894060B2 (en)	2000-03-30	2005-05-17	3M Innovative Properties Company	Method for the treatment of dermal lesions caused by envenomation
US20020055517A1 (en) *	2000-09-15	2002-05-09	3M Innovative Properties Company	Methods for delaying recurrence of herpes virus symptoms
JP2002145777A (ja)	2000-11-06	2002-05-22	Sumitomo Pharmaceut Co Ltd	アラキドン酸誘発皮膚疾患治療剤
US6677347B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Sulfonamido ether substituted imidazoquinolines
US6545016B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Amide substituted imidazopyridines
EP1360486A2 (en)	2000-12-08	2003-11-12	3M Innovative Properties Company	Screening method for identifying compounds that selectively induce interferon alpha
UA74852C2 (en)	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
US6525064B1 (en) *	2000-12-08	2003-02-25	3M Innovative Properties Company	Sulfonamido substituted imidazopyridines
US6660747B2 (en)	2000-12-08	2003-12-09	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6664264B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6545017B1 (en) *	2000-12-08	2003-04-08	3M Innovative Properties Company	Urea substituted imidazopyridines
US6664265B2 (en) *	2000-12-08	2003-12-16	3M Innovative Properties Company	Amido ether substituted imidazoquinolines
US6664260B2 (en)	2000-12-08	2003-12-16	3M Innovative Properties Company	Heterocyclic ether substituted imidazoquinolines
UA74593C2 (en)	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines
US6667312B2 (en)	2000-12-08	2003-12-23	3M Innovative Properties Company	Thioether substituted imidazoquinolines
US6677348B2 (en)	2000-12-08	2004-01-13	3M Innovative Properties Company	Aryl ether substituted imidazoquinolines
US6660735B2 (en) *	2000-12-08	2003-12-09	3M Innovative Properties Company	Urea substituted imidazoquinoline ethers
CN1523987A (zh)	2001-06-15	2004-08-25	3M创新有限公司	治疗牙周疾病的免疫反应调节剂
CA2458876A1 (en)	2001-08-30	2003-03-13	3M Innovative Properties Company	Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
EP1478371A4 (en)	2001-10-12	2007-11-07	Univ Iowa Res Found	METHOD AND PRODUCTS FOR IMPROVING IMMUNE RESPONSES WITH IMIDAZOCHINOLINE COMPOUNDS
DE60230340D1 (de)	2001-11-16	2009-01-22	3M Innovative Properties Co	N-Ä4-(4-Amino-2-ethyl-1H-imidazoÄ4,5-cÜchinolin-1-yl)butylÜmethanesulfonamide, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung
CA2467828C (en)	2001-11-29	2011-10-04	3M Innovative Properties Company	Pharmaceutical formulations comprising an immune response modifier
WO2004080430A2 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Methods of improving skin quality
US6677349B1 (en)	2001-12-21	2004-01-13	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
PT1478327E (pt)	2002-02-22	2015-08-04	Meda Ab	Método de redução e tratamento de imunossupressão induzida por uvb
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
AU2003233519A1 (en)	2002-05-29	2003-12-19	3M Innovative Properties Company	Process for imidazo(4,5-c)pyridin-4-amines
JP2005538057A (ja)	2002-06-07	2005-12-15	スリーエムイノベイティブプロパティズカンパニー	エーテル置換イミダゾピリジン
US7427629B2 (en)	2002-08-15	2008-09-23	3M Innovative Properties Company	Immunostimulatory compositions and methods of stimulating an immune response
JP2006503068A (ja)	2002-09-26	2006-01-26	スリーエムイノベイティブプロパティズカンパニー	１ｈ−イミダゾダイマー
WO2004053452A2 (en)	2002-12-11	2004-06-24	3M Innovative Properties Company	Assays relating to toll-like receptor activity
WO2004053057A2 (en)	2002-12-11	2004-06-24	3M Innovative Properties Company	Gene expression systems and recombinant cell lines
EP1590348A1 (en) *	2002-12-20	2005-11-02	3M Innovative Properties Company	Aryl / hetaryl substituted imidazoquinolines
EP2572714A1 (en)	2002-12-30	2013-03-27	3M Innovative Properties Company	Immunostimulatory Combinations
WO2004071459A2 (en)	2003-02-13	2004-08-26	3M Innovative Properties Company	Methods and compositions related to irm compounds and toll-like receptor 8
US7485432B2 (en)	2003-02-27	2009-02-03	3M Innovative Properties Company	Selective modulation of TLR-mediated biological activity
EP1601365A4 (en)	2003-03-04	2009-11-11	3M Innovative Properties Co	PROPHYLACTIC TREATMENT OF UV-INDUCED EPIDERMAL NEOPLASIA
WO2004080398A2 (en)	2003-03-07	2004-09-23	3M Innovative Properties Company	1-amino 1h-imidazoquinolines
JP2006523212A (ja)	2003-03-13	2006-10-12	スリーエムイノベイティブプロパティズカンパニー	皮膚病変の診断方法
AU2004220465A1 (en)	2003-03-13	2004-09-23	3M Innovative Properties Company	Method of tattoo removal
US20040192585A1 (en)	2003-03-25	2004-09-30	3M Innovative Properties Company	Treatment for basal cell carcinoma
US20040191833A1 (en)	2003-03-25	2004-09-30	3M Innovative Properties Company	Selective activation of cellular activities mediated through a common toll-like receptor
AU2004244962A1 (en)	2003-04-10	2004-12-16	3M Innovative Properties Company	Delivery of immune response modifier compounds using metal-containing particulate support materials
ATE465742T1 (de)	2003-09-05	2010-05-15	Anadys Pharmaceuticals Inc	Tlr7-liganden zur behandlung von hepatitis c

2001
- 2001-06-12 UA UA2003065275A patent/UA74852C2/uk unknown
- 2001-06-12 UA UA2003065277A patent/UA75622C2/uk unknown
- 2001-12-06 HU HU0400710A patent/HUP0400710A2/hu unknown
- 2001-12-06 AT AT01987297T patent/ATE296301T1/de active
- 2001-12-06 ES ES01987283T patent/ES2281456T3/es not_active Expired - Lifetime
- 2001-12-06 CN CNB018201598A patent/CN1247575C/zh not_active Expired - Fee Related
- 2001-12-06 MX MXPA03005011A patent/MXPA03005011A/es active IP Right Grant
- 2001-12-06 KR KR10-2003-7007535A patent/KR20040028690A/ko not_active Withdrawn
- 2001-12-06 MX MXPA03004974A patent/MXPA03004974A/es active IP Right Grant
- 2001-12-06 NZ NZ526087A patent/NZ526087A/en unknown
- 2001-12-06 AU AU3951702A patent/AU3951702A/xx active Pending
- 2001-12-06 CZ CZ20031592A patent/CZ303462B6/cs not_active IP Right Cessation
- 2001-12-06 JP JP2002547926A patent/JP2004523498A/ja active Pending
- 2001-12-06 JP JP2002547927A patent/JP2004529078A/ja active Pending
- 2001-12-06 BR BRPI0116032-0A patent/BR0116032A/pt not_active IP Right Cessation
- 2001-12-06 SK SK710-2003A patent/SK287264B6/sk not_active IP Right Cessation
- 2001-12-06 DK DK01987283T patent/DK1341790T3/da active
- 2001-12-06 PL PL01365883A patent/PL365883A1/xx not_active Application Discontinuation
- 2001-12-06 PL PL392462A patent/PL392462A1/pl unknown
- 2001-12-06 CZ CZ20031562A patent/CZ20031562A3/cs unknown
- 2001-12-06 IL IL15595001A patent/IL155950A0/xx unknown
- 2001-12-06 CZ CZ20031560A patent/CZ295848B6/cs not_active IP Right Cessation
- 2001-12-06 EE EEP200300271A patent/EE200300271A/xx unknown
- 2001-12-06 SK SK684-2003A patent/SK6842003A3/sk not_active Application Discontinuation
- 2001-12-06 CA CA002436984A patent/CA2436984A1/en not_active Abandoned
- 2001-12-06 IL IL15604301A patent/IL156043A0/xx unknown
- 2001-12-06 RU RU2003116123/04A patent/RU2003116123A/ru not_active Application Discontinuation
- 2001-12-06 AU AU2002230618A patent/AU2002230618B2/en not_active Ceased
- 2001-12-06 EP EP01987283A patent/EP1341790B1/en not_active Expired - Lifetime
- 2001-12-06 US US10/013,202 patent/US6670372B2/en not_active Expired - Fee Related
- 2001-12-06 IL IL15588401A patent/IL155884A0/xx unknown
- 2001-12-06 SI SI200130720T patent/SI1341790T1/sl unknown
- 2001-12-06 CN CNB01820161XA patent/CN1253452C/zh not_active Expired - Fee Related
- 2001-12-06 PT PT01987297T patent/PT1341791E/pt unknown
- 2001-12-06 JP JP2002547929A patent/JP2004515500A/ja not_active Withdrawn
- 2001-12-06 CA CA2436980A patent/CA2436980C/en not_active Expired - Fee Related
- 2001-12-06 JP JP2002547928A patent/JP2004521092A/ja not_active Ceased
- 2001-12-06 AU AU3249702A patent/AU3249702A/xx active Pending
- 2001-12-06 JP JP2002547930A patent/JP2004515501A/ja active Pending
- 2001-12-06 BR BR0116047-8A patent/BR0116047A/pt not_active IP Right Cessation
- 2001-12-06 AT AT01992018T patent/ATE319711T1/de not_active IP Right Cessation
- 2001-12-06 AU AU2002239517A patent/AU2002239517B2/en not_active Ceased
- 2001-12-06 WO PCT/US2001/046704 patent/WO2002046193A2/en not_active Ceased
- 2001-12-06 SK SK711-2003A patent/SK7112003A3/sk unknown
- 2001-12-06 HR HR20030464A patent/HRP20030464A2/hr not_active Application Discontinuation
- 2001-12-06 DK DK01987297T patent/DK1341791T3/da active
- 2001-12-06 EP EP01987282A patent/EP1341789A2/en not_active Ceased
- 2001-12-06 AU AU3953002A patent/AU3953002A/xx active Pending
- 2001-12-06 NZ NZ526106A patent/NZ526106A/en not_active IP Right Cessation
- 2001-12-06 HR HR20030466A patent/HRP20030466A2/hr not_active Application Discontinuation
- 2001-12-06 AU AU2002239516A patent/AU2002239516B2/en not_active Ceased
- 2001-12-06 IL IL15604401A patent/IL156044A0/xx unknown
- 2001-12-06 CA CA002436983A patent/CA2436983A1/en not_active Abandoned
- 2001-12-06 NZ NZ526089A patent/NZ526089A/en unknown
- 2001-12-06 RU RU2003116063/04A patent/RU2003116063A/ru not_active Application Discontinuation
- 2001-12-06 KR KR10-2003-7007534A patent/KR20030070049A/ko not_active Abandoned
- 2001-12-06 EE EEP200300270A patent/EE200300270A/xx unknown
- 2001-12-06 WO PCT/US2001/046697 patent/WO2002046192A2/en not_active Ceased
- 2001-12-06 CN CNB018201679A patent/CN1297554C/zh not_active Expired - Fee Related
- 2001-12-06 AU AU3248202A patent/AU3248202A/xx active Pending
- 2001-12-06 AU AU3061802A patent/AU3061802A/xx active Pending
- 2001-12-06 CZ CZ20031591A patent/CZ20031591A3/cs unknown
- 2001-12-06 NZ NZ526105A patent/NZ526105A/en unknown
- 2001-12-06 KR KR10-2003-7007538A patent/KR20040028691A/ko not_active Withdrawn
- 2001-12-06 EE EEP200300268A patent/EE200300268A/xx unknown
- 2001-12-06 WO PCT/US2001/046359 patent/WO2002046188A2/en not_active Ceased
- 2001-12-06 BR BRPI0116464-3A patent/BR0116464A/pt not_active IP Right Cessation
- 2001-12-06 WO PCT/US2001/046696 patent/WO2002046191A2/en not_active Ceased
- 2001-12-06 WO PCT/US2001/046581 patent/WO2002046189A2/en not_active Ceased
- 2001-12-06 CZ CZ20031561A patent/CZ20031561A3/cs unknown
- 2001-12-06 ES ES01987297T patent/ES2242782T3/es not_active Expired - Lifetime
- 2001-12-06 AT AT01987283T patent/ATE353895T1/de not_active IP Right Cessation
- 2001-12-06 HU HU0700062A patent/HUP0700062A2/hu active IP Right Revival
- 2001-12-06 KR KR10-2003-7007532A patent/KR20040023576A/ko not_active Withdrawn
- 2001-12-06 DK DK01992018T patent/DK1343784T3/da active
- 2001-12-06 AU AU3951602A patent/AU3951602A/xx active Pending
- 2001-12-06 AU AU2002232497A patent/AU2002232497B2/en not_active Ceased
- 2001-12-06 MX MXPA03004973A patent/MXPA03004973A/es not_active Application Discontinuation
- 2001-12-06 IL IL15590301A patent/IL155903A0/xx unknown
- 2001-12-06 RU RU2003116649/04A patent/RU2351598C2/ru not_active IP Right Cessation
- 2001-12-06 PT PT01987283T patent/PT1341790E/pt unknown
- 2001-12-06 CZ CZ20031563A patent/CZ20031563A3/cs unknown
- 2001-12-06 MX MXPA03004972A patent/MXPA03004972A/es active IP Right Grant
- 2001-12-06 EP EP01987297A patent/EP1341791B1/en not_active Expired - Lifetime
- 2001-12-06 PL PL01365995A patent/PL365995A1/xx unknown
- 2001-12-06 WO PCT/US2001/046582 patent/WO2002046190A2/en not_active Ceased
- 2001-12-06 KR KR10-2003-7007539A patent/KR20040047733A/ko not_active Withdrawn
- 2001-12-06 DE DE60117859T patent/DE60117859T2/de not_active Expired - Fee Related
- 2001-12-06 CN CNB018199070A patent/CN1252070C/zh not_active Expired - Fee Related
- 2001-12-06 SK SK713-2003A patent/SK287732B6/sk not_active IP Right Cessation
- 2001-12-06 PL PL01365907A patent/PL365907A1/xx not_active Application Discontinuation
- 2001-12-06 DE DE60126645T patent/DE60126645T2/de not_active Expired - Fee Related
- 2001-12-06 CA CA002431151A patent/CA2431151A1/en not_active Withdrawn
- 2001-12-06 PL PL01366115A patent/PL366115A1/xx not_active Application Discontinuation
- 2001-12-06 HU HU0600605A patent/HUP0600605A2/hu unknown
- 2001-12-06 CN CNA018201687A patent/CN1479739A/zh active Pending
- 2001-12-06 PL PL366330A patent/PL207340B1/pl not_active IP Right Cessation
- 2001-12-06 EE EEP200300275A patent/EE200300275A/xx unknown
- 2001-12-06 HR HR20030463A patent/HRP20030463A2/xx not_active Application Discontinuation
- 2001-12-06 SK SK712-2003A patent/SK7122003A3/sk unknown
- 2001-12-06 CA CA002430844A patent/CA2430844A1/en not_active Withdrawn
- 2001-12-06 CN CNA018201725A patent/CN1894244A/zh active Pending
- 2001-12-06 HU HU0400704A patent/HUP0400704A2/hu unknown
- 2001-12-06 PL PL01361948A patent/PL361948A1/xx not_active Application Discontinuation
- 2001-12-06 RU RU2003116061/04A patent/RU2315049C2/ru not_active IP Right Cessation
- 2001-12-06 EP EP01990852A patent/EP1339715A2/en not_active Withdrawn
- 2001-12-06 BR BR0116470-8A patent/BR0116470A/pt not_active IP Right Cessation
- 2001-12-06 RU RU2003116059/04A patent/RU2308456C2/ru not_active IP Right Cessation
- 2001-12-06 KR KR10-2003-7007537A patent/KR20030070050A/ko not_active Withdrawn
- 2001-12-06 JP JP2002547925A patent/JP4437189B2/ja not_active Expired - Fee Related
- 2001-12-06 HU HU0600338A patent/HUP0600338A2/hu active IP Right Revival
- 2001-12-06 IL IL15590401A patent/IL155904A0/xx unknown
- 2001-12-06 NZ NZ526088A patent/NZ526088A/xx unknown
- 2001-12-06 BR BRPI0116052-4A patent/BR0116052A/pt not_active Application Discontinuation
- 2001-12-06 HR HR20030461A patent/HRP20030461A2/hr not_active Application Discontinuation
- 2001-12-06 SK SK715-2003A patent/SK7152003A3/sk unknown
- 2001-12-06 EP EP01992018A patent/EP1343784B1/en not_active Expired - Lifetime
- 2001-12-06 US US10/012,599 patent/US6683088B2/en not_active Expired - Fee Related
- 2001-12-06 CA CA2436846A patent/CA2436846C/en not_active Expired - Fee Related
- 2001-12-06 AU AU2002239530A patent/AU2002239530B2/en not_active Ceased
- 2001-12-06 DE DE60111076T patent/DE60111076T2/de not_active Expired - Lifetime
- 2001-12-06 MX MXPA03005012A patent/MXPA03005012A/es active IP Right Grant
- 2001-12-06 US US10/013,060 patent/US6656938B2/en not_active Expired - Fee Related
- 2001-12-06 HR HR20030462A patent/HRP20030462A2/xx not_active Application Discontinuation
- 2001-12-06 NZ NZ526086A patent/NZ526086A/en unknown
- 2001-12-06 EP EP01992005A patent/EP1341792A2/en not_active Withdrawn
- 2001-12-06 BR BR0116026-5A patent/BR0116026A/pt not_active IP Right Cessation
- 2001-12-06 EE EEP200300274A patent/EE200300274A/xx unknown
- 2001-12-06 EE EEP200300272A patent/EE200300272A/xx unknown
- 2001-12-06 AU AU2002232482A patent/AU2002232482B2/en not_active Ceased
- 2001-12-06 ES ES01992018T patent/ES2260323T3/es not_active Expired - Lifetime
- 2001-12-06 MX MXPA03004975A patent/MXPA03004975A/es active IP Right Grant
- 2001-12-06 HU HU0600600A patent/HUP0600600A2/hu unknown
- 2001-12-06 RU RU2003116060/04A patent/RU2302418C2/ru active
- 2001-12-06 HR HR20030467A patent/HRP20030467B1/xx not_active IP Right Cessation
- 2001-12-07 TW TW090130402A patent/TWI222972B/zh active
- 2001-12-07 TW TW090130404A patent/TWI293300B/zh active
- 2001-12-07 TW TW090130401A patent/TW584633B/zh not_active IP Right Cessation
- 2001-12-10 AR ARP010105726A patent/AR035664A1/es active IP Right Grant
- 2001-12-10 AR ARP010105729A patent/AR035667A1/es unknown
- 2001-12-10 AR ARP010105728A patent/AR035666A1/es unknown
- 2001-12-10 AR ARP010105730A patent/AR035668A1/es unknown
- 2001-12-10 AR ARP010105731A patent/AR035669A1/es unknown
- 2001-12-10 AR ARP010105727A patent/AR035665A1/es unknown
2003
- 2003-05-28 NO NO20032451A patent/NO20032451L/no not_active Application Discontinuation
- 2003-05-28 NO NO20032449A patent/NO20032449L/no not_active Application Discontinuation
- 2003-05-28 NO NO20032452A patent/NO20032452L/no not_active Application Discontinuation
- 2003-05-30 NO NO20032473A patent/NO326159B1/no not_active IP Right Cessation
- 2003-06-06 NO NO20032595A patent/NO20032595D0/no not_active Application Discontinuation
- 2003-06-06 NO NO20032596A patent/NO20032596D0/no not_active Application Discontinuation
- 2003-07-08 ZA ZA200305274A patent/ZA200305274B/en unknown
- 2003-07-08 ZA ZA200305273A patent/ZA200305273B/en unknown
- 2003-07-08 ZA ZA200305270A patent/ZA200305270B/en unknown
- 2003-07-08 ZA ZA200305271A patent/ZA200305271B/en unknown
- 2003-07-08 ZA ZA2003/05272A patent/ZA200305272B/en unknown
- 2003-07-08 ZA ZA200305275A patent/ZA200305275B/en unknown
- 2003-10-07 US US10/680,989 patent/US7049439B2/en not_active Expired - Fee Related
- 2003-10-29 US US10/696,753 patent/US6953804B2/en not_active Expired - Fee Related
- 2003-10-29 US US10/696,476 patent/US20040092545A1/en not_active Abandoned
2005
- 2005-02-28 US US11/069,033 patent/US7132429B2/en not_active Expired - Fee Related
- 2005-05-19 US US11/132,900 patent/US7612083B2/en not_active Expired - Fee Related
- 2005-08-24 CY CY20051101024T patent/CY1105586T1/el unknown
2007
- 2007-05-09 CY CY20071100621T patent/CY1106569T1/el unknown
2009
- 2009-11-06 JP JP2009255040A patent/JP2010031040A/ja not_active Ceased

Also Published As

Publication number	Publication date
NZ526105A (en)	2004-11-26
ZA200305273B (en)	2004-10-08
CA2436846C (en)	2010-11-16
IL155903A0 (en)	2003-12-23
CZ303462B6 (cs)	2012-09-26
EP1341789A2 (en)	2003-09-10
WO2002046191A3 (en)	2003-03-13
AU2002239517B2 (en)	2006-11-02
US20040092545A1 (en)	2004-05-13
AR035669A1 (es)	2004-06-23
HRP20030466A2 (en)	2004-06-30
AU3953002A (en)	2002-06-18
EE200300272A (et)	2003-10-15
ES2242782T3 (es)	2005-11-16
HRP20030463A2 (en)	2004-04-30
WO2002046192A3 (en)	2003-02-13
AU3951602A (en)	2002-06-18
SK7122003A3 (en)	2003-11-04
WO2002046189A3 (en)	2003-03-20
EE200300268A (et)	2003-10-15
RU2003116649A (ru)	2005-02-10
UA75622C2 (en)	2006-05-15
MXPA03005012A (es)	2003-09-05
WO2002046188A2 (en)	2002-06-13
NO20032451D0 (no)	2003-05-28
NO20032473D0 (no)	2003-05-30
WO2002046193A3 (en)	2003-02-27
AU3951702A (en)	2002-06-18
NO326159B1 (no)	2008-10-13
DE60126645T2 (de)	2007-11-22
WO2002046192A2 (en)	2002-06-13
NO20032452L (no)	2003-07-16
AU2002239516B2 (en)	2006-11-09
US7049439B2 (en)	2006-05-23
IL155950A0 (en)	2003-12-23
WO2002046191A2 (en)	2002-06-13
ZA200305272B (en)	2005-01-26
AR035664A1 (es)	2004-06-23
BR0116464A (pt)	2006-02-21
NZ526089A (en)	2004-11-26
HK1066005A1 (en)	2005-03-11
RU2315049C2 (ru)	2008-01-20
AU2002230618B2 (en)	2006-11-02
DK1343784T3 (da)	2006-07-10
NZ526088A (en)	2004-12-24
PL365907A1 (en)	2005-01-10
PL365995A1 (en)	2005-01-24
AR035667A1 (es)	2004-06-23
PL392462A1 (pl)	2010-11-22
AR035665A1 (es)	2004-06-23
CZ20031563A3 (cs)	2004-02-18
RU2003116123A (ru)	2004-11-20
NO20032596L (no)	2003-06-06
NZ526086A (en)	2005-11-25
AU2002232497B2 (en)	2006-11-02
KR20040047733A (ko)	2004-06-05
ES2260323T3 (es)	2006-11-01
RU2003116059A (ru)	2005-02-10
MXPA03004975A (es)	2003-09-05
PL366115A1 (en)	2005-01-24
CN1479739A (zh)	2004-03-03
HK1069166A1 (en)	2005-05-13
NZ526087A (en)	2004-11-26
AR035668A1 (es)	2004-06-23
ZA200305274B (en)	2004-10-18
HRP20030461A2 (en)	2004-06-30
EE200300275A (et)	2003-10-15
JP2004515500A (ja)	2004-05-27
WO2002046188A3 (en)	2003-03-13
WO2002046190A3 (en)	2003-07-17
NZ526106A (en)	2004-11-26
CN1247575C (zh)	2006-03-29
DE60117859D1 (de)	2006-05-04
ES2281456T3 (es)	2007-10-01
SK7152003A3 (en)	2003-09-11
TW584633B (en)	2004-04-21
SK7102003A3 (en)	2003-10-07
EP1341791B1 (en)	2005-05-25
ZA200305270B (en)	2004-08-26
BR0116047A (pt)	2003-09-30
CZ295848B6 (cs)	2005-11-16
CN1479738A (zh)	2004-03-03
US7132429B2 (en)	2006-11-07
PL361948A1 (en)	2004-10-18
JP2004529078A (ja)	2004-09-24
CA2431151A1 (en)	2002-06-13
AU3249702A (en)	2002-06-18
DE60126645D1 (de)	2007-03-29
CY1105586T1 (el)	2010-07-28
NO20032451L (no)	2003-07-16
AU2002239530B2 (en)	2006-09-28
US20050148619A1 (en)	2005-07-07
KR20030070050A (ko)	2003-08-27
CA2436980C (en)	2011-03-29
JP2004521092A (ja)	2004-07-15
NO20032595L (no)	2003-06-06
US6656938B2 (en)	2003-12-02
EP1343784A2 (en)	2003-09-17
US20050234088A1 (en)	2005-10-20
EP1339715A2 (en)	2003-09-03
US20040106640A1 (en)	2004-06-03
SK6842003A3 (en)	2003-12-02
HUP0600600A2 (en)	2006-11-28
BR0116052A (pt)	2006-02-21
CN1537111A (zh)	2004-10-13
CA2436846A1 (en)	2002-06-13
KR20040028690A (ko)	2004-04-03
RU2351598C2 (ru)	2009-04-10
PL366330A1 (en)	2005-01-24
TWI293300B (en)	2008-02-11
HRP20030464A2 (en)	2004-06-30
PT1341790E (pt)	2007-05-31
ZA200305271B (en)	2004-10-08
JP2004532810A (ja)	2004-10-28
CZ20031592A3 (cs)	2004-01-14
EE200300270A (et)	2003-10-15
US20030212091A1 (en)	2003-11-13
CN1297554C (zh)	2007-01-31
BR0116032A (pt)	2006-02-21
WO2002046193A2 (en)	2002-06-13
HK1064383A1 (en)	2005-01-28
KR20030070049A (ko)	2003-08-27
JP2010031040A (ja)	2010-02-12
HUP0600605A2 (en)	2006-11-28
NO20032452D0 (no)	2003-05-28
SK7132003A3 (en)	2003-10-07
PL365883A1 (en)	2005-01-10
SK287732B6 (en)	2011-07-06
ATE296301T1 (de)	2005-06-15
US20040077678A1 (en)	2004-04-22
BR0116026A (pt)	2004-12-21
IL156044A0 (en)	2003-12-23
AR035666A1 (es)	2004-06-23
AU3061802A (en)	2002-06-18
CA2436984A1 (en)	2002-06-13
KR20040023576A (ko)	2004-03-18
ATE319711T1 (de)	2006-03-15
MXPA03004972A (es)	2004-01-29
ZA200305275B (en)	2004-10-08
HRP20030467B1 (hr)	2009-04-30
RU2302418C2 (ru)	2007-07-10
EP1343784B1 (en)	2006-03-08
EE200300274A (et)	2003-10-15
AU2002232482B2 (en)	2006-10-19
US6683088B2 (en)	2004-01-27
CN1252070C (zh)	2006-04-19
WO2002046190A2 (en)	2002-06-13
JP2004523498A (ja)	2004-08-05
MXPA03004973A (es)	2004-01-29
EP1341790B1 (en)	2007-02-14
US6953804B2 (en)	2005-10-11
MXPA03005011A (es)	2003-09-05
CA2430844A1 (en)	2002-06-13
HUP0600338A2 (en)	2006-08-28
HRP20030467A2 (en)	2004-04-30
CA2436983A1 (en)	2002-06-13
JP4437189B2 (ja)	2010-03-24
CZ20031591A3 (cs)	2003-11-12
UA74852C2 (en)	2006-02-15
DE60111076D1 (en)	2005-06-30
NO20032449D0 (no)	2003-05-28
IL155884A0 (en)	2003-12-23
HUP0400710A2 (hu)	2004-06-28
DK1341791T3 (da)	2005-09-19
CN1511155A (zh)	2004-07-07
CY1106569T1 (el)	2012-01-25
ATE353895T1 (de)	2007-03-15
JP2004515501A (ja)	2004-05-27
US6670372B2 (en)	2003-12-30
NO20032595D0 (no)	2003-06-06
EE200300271A (et)	2003-10-15
NO20032473L (no)	2003-05-30
AU3248202A (en)	2002-06-18
SK287264B6 (sk)	2010-04-07
DE60111076T2 (de)	2006-05-04
US20030158192A1 (en)	2003-08-21
HUP0400704A2 (hu)	2004-06-28
EP1341790A2 (en)	2003-09-10
TWI222972B (en)	2004-11-01
EP1341791A2 (en)	2003-09-10
CZ20031562A3 (en)	2004-03-17
CN1894244A (zh)	2007-01-10
US20020193396A1 (en)	2002-12-19
SK7112003A3 (en)	2003-12-02
IL156043A0 (en)	2003-12-23
DE60117859T2 (de)	2006-11-23
BR0116470A (pt)	2005-08-16
PT1341791E (pt)	2005-09-30
IL155904A0 (en)	2003-12-23
RU2003116063A (ru)	2004-12-10
PL207340B1 (pl)	2010-12-31
US7612083B2 (en)	2009-11-03
CN1487939A (zh)	2004-04-07
EP1341792A2 (en)	2003-09-10
NO20032596D0 (no)	2003-06-06
NO20032449L (no)	2003-05-28
CA2436980A1 (en)	2002-06-13
RU2308456C2 (ru)	2007-10-20
SI1341790T1 (sl)	2007-06-30
CZ20031560A3 (en)	2004-05-12
HRP20030462A2 (en)	2004-04-30
CZ20031561A3 (cs)	2004-04-14
HUP0700062A2 (en)	2007-05-02
MXPA03004974A (es)	2003-09-05
KR20040028691A (ko)	2004-04-03
WO2002046189A2 (en)	2002-06-13
CN1253452C (zh)	2006-04-26

Publication	Publication Date	Title
NO20032473L (no)	2003-05-30	Sulfonamidoetersubstituerte imidazokinoliner
DK1292604T3 (da)	2009-06-15	2-Aminocarbonyl-9H-purinderivater
ATE288437T1 (de)	2005-02-15	Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DK1280809T3 (da)	2005-11-07	Antitumorecteinascidinderivater
AR028393A1 (es)	2003-05-07	Iminoazidas substituidas
ATE298332T1 (de)	2005-07-15	Decahydro-isochinolinderivate
DK1368299T3 (da)	2006-11-27	Substituerede C-cyclohexylmethylaminderivater
AR028602A1 (es)	2003-05-14	Derivados de pirrol
AR028282A1 (es)	2003-04-30	Derivados de aminofenil pirimidona
ATE282021T1 (de)	2004-11-15	Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322592T3 (da)	2004-11-22	Substituerede 1-aminobutan-3-ol-derivater
PT1351959E (pt)	2005-09-30	Novos derivados de pleuromutilina
ATE280752T1 (de)	2004-11-15	Aminomethyl-phenyl-cyclohexanonderivate
DK1322590T3 (da)	2007-09-03	Substituerede 5-amino-1-penten-3-ol-derivater
ATE374776T1 (de)	2007-10-15	Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no)	2002-09-13	2-fenylpyran-4-on-derivater
DK1246793T3 (da)	2005-02-21	Substituerede aminomethyl-phenyl-cyclohexanderivater